Industry News
Stay up to date with the latest news in the industry
LATEST NEWS
Pfizer has suspended a Phase III trial of the investigational drug figitumumab in patients with advanced non-small cell lung cancer (NSCLC) after a safety comitee found that the drug is unlikely to have any meaningful effect.
16 March 2010
IBS Drug Market to Triple by 2018
16 March 2010
16 March 2010
Sigma-Aldrich to Sell Pfizer's Bioactive Small Molecules
15 March 2010
15 March 2010
AstraZeneca's Cancer Drug Fails Trial
15 March 2010
15 March 2010
Watson's Long-Acting Prostate Cancer Agonist Approved
12 March 2010
12 March 2010
Roche and Biogen Halt Ocrelizumab Trials
12 March 2010
12 March 2010
iToxFX Platform to Predict New Drug Safety
11 March 2010
11 March 2010
Good Results for Nektar's Ovarian Cancer Drug
10 March 2010
10 March 2010
Isis To Trial ALS Antisense Drug
10 March 2010
10 March 2010
US Researchers to Develop Bioterror Antidote
09 March 2010
09 March 2010
Sanofi-Aventis's Prostate Cancer Drug Passes Trial
09 March 2010
09 March 2010
Good Results for Investigational Anticoagulant Apixaban
08 March 2010
08 March 2010
CombinatoRx's Chronic Painkiller Gets FDA Approval
08 March 2010
08 March 2010
